» Articles » PMID: 25205122

Cell Membrane Penetrating Function of the Nuclear Localization Sequence in Human Cytokine IL-1α

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2014 Sep 11
PMID 25205122
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cytokines are released from the cell, bind to their receptors, and affect cellular responses. The precursor form of interleukin 1 alpha (pIL-1α) has a nuclear localization sequence (NLS) that causes it to be localized to the nucleus and regulate specific gene expression. The amino acids of the NLS are basic amino acid-rich sequences, as is the cell penetrating peptide (CPP), which has been widely studied as a way to deliver macromolecules into cells. Here, we hypothesized that the NLS in pIL-1α (pIL-1αNLS) can penetrate the cell membrane and it could deliver macromolecules such as protein in vivo. We characterized cell membrane penetration ability of pIL-1αNLS or its tandem repeated form (2pIL-1αNLS) to enhance its intracellular delivery efficiency. 2pIL-1αNLS showed comparable protein delivery efficiency to TAT-CPP and it mediates endocytosis following heparan sulfate interaction. 2pIL-1αNLS conjugated enhanced green fluorescence protein was localized to the nucleus and the cytoplasm. Intra-peritoneal administration of 2pIL-1αNLS conjugated dTomato protein showed remarkable in vivo intracellular delivery efficiency in various tissues including spleen, liver, and intestine in mice. Moreover, cytotoxicity of 2pIL-1αNLS was not observed even at 100 μM. Our results demonstrate cell membrane-penetrating function of NLS in pIL-1α, which can be used as a safe therapeutic macromolecular delivery peptide.

Citing Articles

Effect of Different Karyophilic Peptides on Physical Characteristics and In Vitro Transfection Efficiency of Chitosan-Plasmid Nanoparticles as Nonviral Gene Delivery Systems.

Aranda-Barradas M, Coronado-Contreras H, Aguilar-Castaneda Y, Olivo-Escalante K, Gonzalez-Diaz F, Garcia-Tovar C Mol Biotechnol. 2024; 67(2):723-733.

PMID: 38400988 PMC: 11711767. DOI: 10.1007/s12033-024-01087-9.


Cell-Penetrating Peptides.

Zorko M, Langel U Methods Mol Biol. 2021; 2383:3-32.

PMID: 34766279 DOI: 10.1007/978-1-0716-1752-6_1.


The Cysteine-Containing Cell-Penetrating Peptide AP Enables Efficient Macromolecule Delivery to T Cells and Controls Autoimmune Encephalomyelitis.

Kim W, Kim G, Cho H, Choi J Pharmaceutics. 2021; 13(8).

PMID: 34452095 PMC: 8401785. DOI: 10.3390/pharmaceutics13081134.


LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis.

Koo J, Kim D, Cha D, Kang M, Choi J Theranostics. 2020; 10(7):3138-3150.

PMID: 32194859 PMC: 7053182. DOI: 10.7150/thno.43441.


Probing the limits of Q-tag bioconjugation of antibodies.

Marculescu C, Lakshminarayanan A, Gault J, Knight J, Folkes L, Spink T Chem Commun (Camb). 2019; 55(76):11342-11345.

PMID: 31479092 PMC: 6788405. DOI: 10.1039/c9cc02303h.


References
1.
Magnuson D, Knudsen B, Geiger J, Brownstone R, Nath A . Human immunodeficiency virus type 1 tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol. 1995; 37(3):373-80. DOI: 10.1002/ana.410370314. View

2.
Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K . Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem. 2000; 276(8):5836-40. DOI: 10.1074/jbc.M007540200. View

3.
Cardozo A, Buchillier V, Mathieu M, Chen J, Ortis F, Ladriere L . Cell-permeable peptides induce dose- and length-dependent cytotoxic effects. Biochim Biophys Acta. 2007; 1768(9):2222-34. DOI: 10.1016/j.bbamem.2007.06.003. View

4.
Schmidt N, Mishra A, Lai G, Wong G . Arginine-rich cell-penetrating peptides. FEBS Lett. 2009; 584(9):1806-13. DOI: 10.1016/j.febslet.2009.11.046. View

5.
Pestka S, Krause C, Sarkar D, Walter M, Shi Y, Fisher P . Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004; 22:929-79. DOI: 10.1146/annurev.immunol.22.012703.104622. View